The leading European online biotech media, Labiotech.eu, has just published their list of “The 20 European Biotech Companies to Watch in 2022”
The MVA-member companies, Genmab based in Copenhagen and Swedish women’s health company, Gedea Biotech based in Skåne have both made the list, and where as Genmab regularly makes the headlines and is well known to most, Gedea Biotech, is somewhat less known in the broader public. Maybe that is about to change! Among other positive news from Gedea, they recently announced that the company had received funding for microbiome research project with Centre for Translational Microbiome Research at Karolinska Institutet.